Scopolamine Transdermal System
Anticholinergic class · 0 generic manufacturers · 0 ANDAs filed at FDA.
Questions a plan sponsor actually asks.
What is Scopolamine Transdermal System used for?
Scopolamine Transdermal System is tracked in Medicare Part D. Specific indication information is not available in our current dataset.
Is there a generic for Scopolamine Transdermal System?
No. Scopolamine Transdermal System is brand-only with no generic equivalents currently in market.
How much does my plan pay for Scopolamine Transdermal System?
Across 329 Part D plans, Scopolamine Transdermal System averages $4.34/unit (NADAC). Lowest available: $4.34/unit. Highest in distribution: $4.34/unit.
Is Scopolamine Transdermal System on the FDA shortage list?
Scopolamine Transdermal System has been discontinued by its manufacturer(s).
2 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (3 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.